MedTrace Logo

Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement

NCT02786264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2023-04-24

Study results available
· View outcomes & findings →

Summary

This study proposes to perform a descriptive analysis and pilot observational study looking at the types and quantity of anesthetic agents used and their associations with outcomes among patients scheduled to receive transfemoral aortic valve replacements (TAVR) at Yale New Haven Hospital (YNHH).

Conditions

  • Aortic Stenosis

Interventions

DRUG

Dexmedetomidine with propofol

A dexmedetomidine- dominant anesthetic will be defined as an anesthetic that included a continuous infusion of dexmedetomidine within 15 minutes of anesthesia start. This group was subsequently modified in light of retrospective data collection to specify a group receiving dexmedetomidine in combination with propofol.

DRUG

Propofol

A propofol-dominant anesthetic will be defined as an anesthetic that included a continuous infusion of propofol within 15 minutes of anesthesia start. This definition was subsequently modified to include patients who received propofol infusion but not dexmedetomidine.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Robert Schonberger, MD · Yale University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-05-31
Completion
2017-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786264 on ClinicalTrials.gov